Clinical Trial Update: Neoadjuvant Chemotherapy with or Without Talniflumate for the Treatment of Breast Cancer [Phase 4]

View source ↗

Summary

A Phase 4 trial from Shandong University is evaluating whether adding Talniflumate to neoadjuvant chemotherapy improves outcomes in breast cancer; the study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Talniflumate (talniflumate)

Snippet

Sponsor: Shandong University | Conditions: Breast Cancer | Phase 4 | Status: NOT_YET_RECRUITING